Estrogen action: A historic perspective on the implications of considering alternative approaches
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
In the 50 years since the initial reports of a cognate estrogen receptor (ER), much has been learned about the diverse effects and mechanisms of estrogens, such as 17β-estradiol (E2). This expert narrative review briefly summarizes perspectives and/or recent work of the authors, who have been addressing different aspects of estrogen action, but take a common approach of using alternative considerations to gain insight into mechanisms with clinical relevance, and inform future studies, regarding estrogen action. Their “Top Ten” favorite alternatives that are discussed herein are as follows. 1- E2 has actions by binding to a receptor that do not require its enzymatic conversion. 2- Using a different strategy for antibody binding could make the estrogen receptor (ER) more discernible. 3- Blocking ERs, rather than E2 production, may be a useful strategy for breast cancer therapy. 4- Secretion of α-fetoprotein (AFP), rather than only levels of E2 and/or progesterone, may influence breast cancer risk. 5- A peptide derived from the active site of AFP can produce the same benefits of the entire endogenous protein in endocrine cancers. 6- Differential distribution of ER subtypes in the body and brain may underlie specific effects of estrogens. 7- ERβ may be sufficient for the trophic effects of estrogen in the brain, and ERα may be the primary target of trophic effects in the body. 8- ERβ may play a role in the trophic effects of androgens, and may also be relevant in the periphery. 9 - Downstream of E2's effects at ERβ, there may be consequences for biosynthesis of progestogens and/or androgens. 10- Changes in histones and/or other factors, which may be downstream of ERβ, potentially underlie the divergent effects of E2 in the brain and peripheral tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322401 · Cited by 1,487 · cited 1×
“For example, recent studies have further confirmed that the role of E2 to increase risk for breast cancer is widely recognized [73], and greater breast cancer risk has been shown to be associated with high serum E2 [74–77] and administration of E2 to postmenopausal women [78,79].”
Progestin regulation of cellular proliferation.
CLARKE, C. L., & SUTHERLAND, R. L. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-2-266 · Cited by 650 · cited 2×
“For example, unlike its role in the uterus, P4 can have mitogenic effects in breast, primarily via acting at PRs [104].”
Ogawa, S., Chan, J., Gustafsson, J.-A., Korach, K. S., & Pfaff, D. W. (2003) · Endocrinology · doi:10.1210/en.2002-220519 · Cited by 275
Handa, R. J., Pak, T. R., Kudwa, A. E., Lund, T. D., & Hinds, L. (2008) · Hormones and Behavior · doi:10.1016/j.yhbeh.2007.09.012 · Cited by 205
Membrane-Initiated Signaling of Estrogen in the Brain
Rønnekleiv, O., Malyala, A., & Kelly, M. (2007) · Seminars in Reproductive Medicine · doi:10.1055/s-2007-973429 · Cited by 41
Cited by
Liang, J., & Shang, Y. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183708 · Cited by 314
Control of Cognition and Adaptive Behavior by the GLP/G9a Epigenetic Suppressor Complex
Schaefer, A., Sampath, S. C., Intrator, A., Min, A., Gertler, T. S., Surmeier, D. J., Tarakhovsky, A., & Greengard, P. (2009) · Neuron · doi:10.1016/j.neuron.2009.11.019 · Cited by 317
Nanoparticle-mediated targeted drug delivery for breast cancer treatment
Liyanage, P. Y., Hettiarachchi, S. D., Zhou, Y., Ouhtit, A., Seven, E. S., Oztan, C. Y., Celik, E., & Leblanc, R. M. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.04.006 · Cited by 287
Estrogen and thrombosis: a bench to bedside review
Abou-Ismail, M. Y., Citla Sridhar, D., & Nayak, L. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.05.008 · Cited by 261
Hevener, A. L., Zhou, Z., Moore, T. M., Drew, B. G., & Ribas, V. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.06.013 · Cited by 72
Metadata
- Authors
- Jensen, E. V., Jacobson, H. I., Walf, A. A., & Frye, C. A.
- Venue
- Physiology & Behavior
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 99
- Issue
- 2
- Pages
- 151-162
- ISSN
- 0031-9384 (ISSN-L)
- OpenAlex
- W1996167112
- Cited by
- 133
- References
- 5
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.